1. Scrip

Teva launches transdermal fentanyl in the US

 
• By John Davis

[C#198601169:Teva] Pharmaceutical Industrieshas received US FDA approval and started shipping its fentanyl [C#199901331:transdermal] patches, in 25, 50, 75 and 100 μg/hour doses, AB-rated generic versions of Ortho-McNeil's (J&J) Duragesic. Generic fentanyl patches are already available in the US from other companies, including Mylan, [C#198601285:Watson], [C#199902043:Lavipharm] and Actavis. Earlier this year, lots of [C#198601285:Watson]'s and Actavis's versions were separately adversely affected by manufacturing issues. [C#198601169:Teva]'s version is manufactured by Aveva Drug Delivery Systems, a division of [C#200101290:Nitto Denko], which [C#198601169:Teva] describes as one of the world's largest manufacturers of, and pioneer in, drug-in-adhesive [C#199901331:transdermal] patch technology.

Teva Pharmaceutical Industrieshas received US FDA approval and started shipping its fentanyl [transdermal] patches, in 25, 50, 75 and 100 μg/hour doses, AB-rated generic versions of Ortho-McNeil's (J&J) Duragesic. Generic fentanyl patches are already available in the US from other companies, including Mylan, Watson, Lavipharm and Actavis. Earlier this year, lots of Watson's and Actavis's versions were separately adversely affected by manufacturing issues. Teva's version is manufactured by Aveva Drug Delivery Systems, a division of Nitto Denko, which Teva describes as one of the world's largest manufacturers of, and pioneer in, drug-in-adhesive [transdermal] patch technology.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Scrip